Amdocs (BSP:D2OX34) Ending Cash Position: R$1,058 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:D2OX34 Amdocs Ltd BSP:D2OX34
72 GF Score
Price R$37.52
GF Value R$52.64
! 1 Warning Sign
View Full Analysis

What is Amdocs Ending Cash Position?

Amdocs BSP:D2OX34 72 Ending Cash Position is R$1,058 Mil as of Jun. 2026. GuruFocus rates BSP:D2OX34 with a GF Score™ of 72/100 and a GF Value™ of R$52.64. The stock has 1 warning sign investors should review.

Amdocs's Ending Cash Position for the quarter that ended in Jun. 2026 was R$1,058 Mil.

Amdocs's quarterly Ending Cash Position declined from Dec. 2025 (R$1,352 Mil) to Mar. 2026 (R$1,122 Mil) and declined from Mar. 2026 (R$1,122 Mil) to Jun. 2026 (R$1,058 Mil).

Amdocs's annual Ending Cash Position declined from Sep. 2023 (R$2,569 Mil) to Sep. 2024 (R$1,917 Mil) and declined from Sep. 2024 (R$1,917 Mil) to Sep. 2025 (R$1,743 Mil).

Amdocs Ending Cash Position Related Terms

Amdocs Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Amdocs's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amdocs Ending Cash Position Chart

Amdocs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,743.15 3,006.56 2,568.52 1,916.55 1,742.97

Amdocs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,482.46 1,742.97 1,352.33 1,121.72 1,057.88
BSP:D2OX34
72GF Score
Amdocs Ltd BSP:D2OX34
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amdocs Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amdocs's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1856.054+-113.084
=1,743

Amdocs's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1099.094+-41.218
=1,058

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of R$1,058 Mil mean?
Amdocs (BSP:D2OX34) has a Ending Cash Position of R$1,058 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Amdocs and its competitors.
Is Amdocs' Ending Cash Position too high?
Amdocs' current Ending Cash Position is R$1,058 Mil. Overall, Amdocs has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Amdocs' Ending Cash Position compare to MBGL and QLYS?
Amdocs' Ending Cash Position of R$1,058 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Software company?
A good Ending Cash Position depends on the Software industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Amdocs and its competitors. Amdocs's current Ending Cash Position is R$1,058 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amdocs stock overvalued right now?
Amdocs (BSP:D2OX34) has a current Ending Cash Position of R$1,058 Mil. The stock's GF Value™ is R$52.64, compared to a current price of R$37.52 — trading 28.7% below its estimated fair value. The current Ending Cash Position is R$1,058 Mil. Amdocs' overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Amdocs (BSP:D2OX34), the current Ending Cash Position is R$1,058 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amdocs (BSP:D2OX34) Overvalued in 2026?

Based on GuruFocus' analysis, Amdocs stock appears to be undervalued. The current stock price of R$37.52 is trading 28.7% below its estimated GF Value™ of R$52.64.

Key valuation signals for BSP:D2OX34:

  • Ending Cash Position: R$1,058 Mil
  • GF Value™: R$52.64 vs. price of R$37.52 (28.7% below fair value)
  • GF Score™: 72/100 with 1 warning sign

No single metric tells the full story. See the BSP:D2OX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amdocs Business Description

Address 625 Maryville Centre Drive, Suite 200, Saint Louis, MO, USA, 63141
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
72GF Score

Get the complete analysis for BSP:D2OX34

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$37.52
Price
R$52.64
GF Value